NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:Read More
You might also be interested in reading House prices rise for sixth month in a row as first-time buyers race to beat stamp duty hike.